Liv52: Advanced Liver Support for Optimal Hepatic Function

Liv.52

Liv.52

Price from 47.30 $
Product dosage: Drops 100ml
Package (num)Per bottlePriceBuy
2$23.65$47.30 (0%)🛒 Add to cart
3$21.79$70.95 $65.36 (8%)🛒 Add to cart
4$20.86$94.60 $83.42 (12%)🛒 Add to cart
5
$20.30 Best per bottle
$118.25 $101.48 (14%)🛒 Add to cart

Liv52 is a clinically researched hepatoprotective formulation designed to support and restore liver function through a synergistic blend of time-tested herbal ingredients. Developed by Himalaya Wellness, this evidence-based supplement works to enhance detoxification pathways, promote hepatocyte regeneration, and improve metabolic markers of liver health. With over six decades of clinical use and numerous published studies, Liv52 represents a comprehensive approach to maintaining hepatic integrity against various stressors, including environmental toxins, medication metabolism, and lifestyle factors. Its multi-mechanistic action makes it a cornerstone in both preventive hepatology and adjunctive therapeutic protocols.

Features

  • Contains standardized extracts of Capparis spinosa (Himsra), Cichorium intybus (Kasani), Mandur bhasma, Tamarix gallica (Jhavuka), and Terminalia arjuna
  • Dual-action formula: hepatoprotective and regenerative properties
  • Manufactured under GMP-certified facilities with rigorous quality control
  • Vegetarian capsules/tablets free from synthetic binders
  • Stable shelf life of 36 months from manufacturing date
  • Available in both syrup and tablet formulations for flexible dosing

Benefits

  • Enhances liver detoxification capacity by supporting phase I and II enzymatic pathways
  • Promotes hepatocyte regeneration through antioxidant and anti-inflammatory mechanisms
  • Improves markers of liver function, including ALT, AST, and GGT levels
  • Provides protective effects against hepatotoxic substances including alcohol and certain medications
  • Supports protein biosynthesis and overall hepatic metabolic function
  • Maintains healthy lipid metabolism and bilirubin levels

Common use

Liv52 is commonly utilized as a hepatoprotective agent in cases of suboptimal liver function, including early-stage fatty liver disease, medication-induced hepatotoxicity, and alcohol-related liver stress. Healthcare practitioners frequently recommend it as adjunctive therapy alongside conventional treatments for hepatitis, cirrhosis, and other chronic liver conditions. It is also employed preventively for individuals with occupational exposure to hepatic toxins or those taking medications with known hepatotoxic profiles. The formulation is particularly valued for its ability to support liver function during periods of metabolic stress without interfering with prescription medications.

Dosage and direction

Adults and children over 14 years: 2 tablets twice daily, or 2 teaspoonfuls of syrup twice daily, preferably after meals. For therapeutic purposes under medical supervision, dosage may be increased to 3 tablets/syrup servings twice daily. Children 5-14 years: 1 tablet twice daily or 1 teaspoonful twice daily. Tablets should be swallowed whole with water; syrup should be measured using the provided dosing cup. Consistent daily administration at approximately the same times maximizes therapeutic benefits. Treatment duration typically ranges from 3-6 months depending on clinical indication, though maintenance dosing may continue longer under medical guidance.

Precautions

Patients with pre-existing diabetes should monitor blood glucose levels regularly as some ingredients may affect glucose metabolism. Those with iron storage disorders should use caution due to the presence of iron-containing compounds. Pregnancy and lactation require medical consultation before use. Individuals with known allergies to Asteraceae/Compositae plants (such as ragweed, marigolds, or daisies) should exercise caution due to potential cross-reactivity. Regular liver function monitoring is recommended during extended use, particularly in patients with established liver disease. The formulation contains natural ingredients that may potentially interact with blood-thinning medications.

Contraindications

Absolute contraindications include known hypersensitivity to any component of the formulation. Not recommended for children under 5 years of age due to insufficient safety data. Contraindicated in patients with acute liver failure requiring intensive medical intervention. Should not be used in cases of biliary obstruction without simultaneous medical management. Patients with hemochromatosis or other iron overload disorders should avoid use due to iron content. Not indicated for treatment of acute viral hepatitis without concurrent antiviral therapy.

Possible side effects

Clinical studies report excellent tolerability with minimal adverse effects. Rare cases (<0.1%) of gastrointestinal discomfort, including mild nausea or epigastric fullness, typically resolve with continued use. Hypersensitivity reactions including rash or urticaria may occur in predisposed individuals. Isolated reports of headache and dizziness, usually transient and dose-related. No documented cases of hepatotoxicity from proper use. Any persistent adverse effects should prompt discontinuation and medical consultation.

Drug interaction

May potentiate effects of anticoagulant/antiplatelet medications (warfarin, aspirin, clopidogrel) through mild antiplatelet activity of certain botanical components. Theoretical interaction with immunosuppressants due to potential immunomodulatory effects. May enhance hypoglycemic effects of diabetes medications. Could potentially interfere with absorption of tetracycline antibiotics and iron supplements if taken simultaneously—separate administration by at least 2 hours. No significant interactions documented with most prescription medications, though healthcare provider review is recommended for patients on multiple pharmacotherapies.

Missed dose

If a dose is missed, take it as soon as remembered unless it is nearly time for the next scheduled dose. Do not double the dose to make up for a missed administration. Maintain regular dosing schedule thereafter. The hepatoprotective effects are cumulative, so occasional missed doses are unlikely to significantly impact overall efficacy, though consistency optimizes therapeutic outcomes.

Overdose

No cases of serious overdose have been reported in clinical literature. Theoretical overdose might manifest as gastrointestinal discomfort, nausea, or headache. Management should include discontinuation, supportive care, and symptomatic treatment. Gastric lavage is not indicated unless massive overdose occurs within a very short timeframe. There is no specific antidote; treatment should focus on symptom management. Contact poison control or seek medical attention if concerning symptoms develop.

Storage

Store at room temperature (15-30°C) in original packaging, protected from light and moisture. Keep container tightly closed when not in use. Do not freeze syrup formulation. Keep out of reach of children and pets. Do not use if seal is broken or packaging appears compromised. Discard any unused portion after the expiration date printed on packaging.

Disclaimer

This information is provided for educational purposes only and does not constitute medical advice. Liv52 is a dietary supplement and should not be used as a substitute for professional medical treatment or diagnosis. Individual results may vary. Always consult with a qualified healthcare provider before starting any new supplement regimen, particularly if you have pre-existing medical conditions or are taking prescription medications. The statements regarding traditional uses have not been evaluated by all regulatory authorities worldwide.

Reviews

Clinical studies spanning decades demonstrate Liv52’s efficacy in improving liver function tests and subjective symptoms of liver distress. A 2016 randomized controlled trial published in the Journal of Clinical and Experimental Hepatology showed significant improvement in ALT and AST levels in patients with non-alcoholic fatty liver disease. Earlier research in the Indian Journal of Gastroenterology demonstrated protective effects against antitubercular drug-induced hepatotoxicity. Patient reports consistently note improvements in energy levels, digestion, and overall well-being. Healthcare practitioners value its safety profile and complementary role in comprehensive liver management protocols.